$2.44
-0.05-2.01%
At close: -
$2.50
0.062.46%
After Hours: Jan 23, 6:13 PM EDT
Comments
Loading...
Pasithea Therapeutics (NASDAQ:KTTA) Stock, Earnings Estimates, EPS, And Revenue
Pasithea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-2.870
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Pasithea Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Pasithea Therapeutics (KTTA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Pasithea Therapeutics (KTTA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?
Pasithea Therapeutics (KTTA) is scheduled to report earnings on March 28, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Pasithea Therapeutics (NASDAQ:KTTA)?
The Actual EPS was $-2.87, which missed the estimate of $0.00.
What were Pasithea Therapeutics’s (NASDAQ:KTTA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.